NEW YORK, May 11 (GenomeWeb News) - The National Institute of Standards and Technology has awarded First Genetic Trust a $2 million Advanced Technology Program grant to develop a pharmacogenomics database, the company said today.
The two-year award will support development of an information system to manage medical and genetic data related to adverse drug reactions and pharmacogenomics. Specifically, the grant will fund a prototype "clearinghouse ... that will support large-scale surveillance and research studies into the genetic basis for adverse drug reactions," according to the project brief.
FGT said that the system will provide patients with a secure communication mechanism that will allow them to interact anonymously with researchers. Conversely, patients can be re-contacted by researchers to participate in research studies, while maintaining their anonymity.